Relmada Therapeutics Inc. (RLMD)
NASDAQ: RLMD
· Real-Time Price · USD
0.60
-0.06 (-9.64%)
At close: Aug 19, 2025, 3:57 PM
0.59
-1.80%
After-hours: Aug 19, 2025, 06:04 PM EDT
Relmada Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 452.00 | 806.00 |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -452 | -806 |
Operating Income | -10.22M | -18.22M | -19.08M | -23.01M | -18.82M | -22.99M | -26.83M | -22.69M | -26.03M | -28.15M | -38.7M | -38.74M | -45.51M | -38.3M | -34.18M | -42.65M | -26.46M | -22.41M |
Interest Income | 321.46K | 440.29K | 654.64K | 856.48K | 963.01K | 1.06M | 1.26M | 1.32M | 1.36M | 1.21M | 1.11M | 827.61K | 387.33K | 329.95K | n/a | 297.65K | 322.81K | 419.97K |
Pretax Income | -9.87M | -17.56M | -18.66M | -21.73M | -17.77M | -21.83M | -25.16M | -22M | -25.3M | -26.32M | -37.94M | -39.42M | -39.94M | -39.75M | -34.38M | -42.61M | -26.55M | -22.21M |
Net Income | -9.87M | -17.56M | -18.66M | -21.73M | -17.77M | -21.83M | -25.16M | -22M | -25.3M | -26.32M | -37.94M | -39.42M | -39.94M | -39.75M | -34.38M | -42.61M | -26.55M | -22.21M |
Selling & General & Admin | 7.4M | 6.27M | 8.08M | 11.86M | 8.1M | 9.68M | 12.08M | 12.24M | 12.29M | 12.29M | 11.83M | 8.21M | 14.6M | 13.29M | 8.91M | 8.66M | 9.13M | 8.38M |
Research & Development | 2.82M | 11.95M | 11M | 11.15M | 10.72M | 13.3M | 14.75M | 10.45M | 13.74M | 15.86M | 26.87M | 30.53M | 30.91M | 25.01M | 25.27M | 33.99M | 17.33M | 14.02M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 10.22M | 18.22M | 19.08M | 23.01M | 18.82M | 22.99M | 26.83M | 22.69M | 26.03M | 28.15M | 38.7M | 38.74M | 45.51M | 38.3M | 34.18M | 42.65M | 26.46M | 22.41M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 10.22M | 18.22M | 19.08M | 23.01M | 18.82M | 22.99M | 26.83M | 22.69M | 26.03M | 28.15M | 38.7M | 38.74M | 45.51M | 38.3M | 34.18M | 42.65M | 26.46M | 22.41M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -26.83K | n/a | n/a | n/a | n/a | n/a | -387K | -330K | -159K | -298K | 90.06K | -190K |
Shares Outstanding (Basic) | 33.19M | 30.41M | 30.17M | 30.17M | 30.17M | 30.13M | 30.1M | 30.1M | 30.1M | 30.1M | 30.1M | 30.06M | 29.94M | 28.39M | 19.08M | 17.48M | 17.05M | 16.57M |
Shares Outstanding (Diluted) | 33.19M | 30.41M | 30.17M | 30.17M | 30.17M | 30.13M | 30.1M | 30.1M | 30.1M | 30.1M | 30.1M | 30.06M | 29.94M | 28.39M | 19.08M | 17.48M | 17.05M | 16.57M |
EPS (Basic) | -0.3 | -0.58 | -0.62 | -0.72 | -0.59 | -0.72 | -0.84 | -0.73 | -0.84 | -0.87 | -1.26 | -1.31 | -1.33 | -1.4 | -1.8 | -2.44 | -1.56 | -1.34 |
EPS (Diluted) | -0.3 | -0.58 | -0.62 | -0.72 | -0.59 | -0.72 | -0.84 | -0.73 | -0.84 | -0.87 | -1.26 | -1.31 | -1.33 | -1.4 | -1.8 | -2.44 | -1.56 | -1.34 |
EBITDA | -10.22M | -18.22M | -18.66M | -23.01M | -18.82M | -19.07M | -25.17M | -22M | -25.39M | -28.15M | -38.7M | -38.74M | -45.51M | -38.3M | -34.38M | -42.65M | -26.46M | -22.4M |
EBIT | -9.87M | -18.22M | -18.66M | -23.01M | -18.82M | -21.83M | -25.17M | -22M | -26.03M | -26.32M | -38.7M | -38.74M | -45.51M | -38.3M | -34.18M | -42.65M | -26.46M | -22.41M |
Depreciation & Amortization | n/a | n/a | n/a | 23.01M | 18.82M | 22.99M | n/a | n/a | 26.03M | 28.15M | -945 | 315.00 | 315.00 | 315.00 | -196K | 250.2K | 452.00 | 806.00 |